Continuous positive airway pressure improves exercise capacity and heart rate recovery in obstructive sleep apnea

International Journal of Cardiology

Volumn 132, Issue 1, 2009, Pages 75-83

  Maeder, Micha T ^a   Ammann, Peter ^a   Münzer, Thomas ^b   Schoch, Otto D ^c   Korte, Wolfgang ^d   Hürny, Christoph ^b   Myers, Jonathan ^e   Rickli, Hans ^a  

^a Division of Cardiology   (Switzerland)

^b Center of Geriatric Medicine and Rehabilitation   (Switzerland)

^c Multidisciplinary Sleep Center   (Switzerland)

^d Institute for Clinical Chemistry and Hematology   (Switzerland)

^e STANFORD UNIVERSITY   (United States)

Author keywords

Continuous positive airway pressure; Exercise capacity; Heart rate recovery; Natriuretic peptide; Obstructive sleep apnea

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CONVALESCENCE; DISEASE SEVERITY; EXERCISE; FEMALE; FOLLOW UP; HEART MUSCLE OXYGEN CONSUMPTION; HEART RATE; HUMAN; MALE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; THERAPY EFFECT; TREATMENT DURATION;

CASE-CONTROL STUDIES; CONTINUOUS POSITIVE AIRWAY PRESSURE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OXYGEN; PEPTIDE FRAGMENTS; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE;

EID: 58849118088     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.10.040     Document Type: Article

References (51)

1. Bradley T.D., and Floras J.S. Sleep apnea and heart failure: part I: obstructive sleep apnea. Circulation 107 (2003) 1671-1678
2. Somers V.K., Dyken M.E., Clary M.P., and Abboud F.M. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96 (1995) 1897-1904
3. Peppard P.E., Young T., Palta M., and Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 (2000) 1378-1384
4. Shivalkar B., Van de Heyning C., Kerremans M., et al. Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol 47 (2006) 1433-1439
5. Arias M.A., Garcia-Rio F., Alonso-Fernandez A., Mediano O., Martinez I., and Villamor J. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 112 (2005) 375-383
6. Wong C.Y., O'Moore-Sullivan T., Leano R., Hukins C., Jenkins C., and Marwick T.H. Association of subclinical right ventricular dysfunction with obesity. J Am Coll Cardiol 47 (2006) 611-616
7. Shahar E., Whitney C.W., Redline S., et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163 (2001) 19-25
8. Kaneko Y., Floras J.S., Usui K., et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348 (2003) 1233-1241
9. Narkiewicz K., Kato M., Phillips B.G., Pesek C.A., Davison D.E., and Somers V.K. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 100 (1999) 2332-2335
10. Arias M.A., Garcia-Rio F., Alonso-Fernandez A., Martinez I., and Villamor J. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J 27 (2006) 1106-1113
11. Myers J., Prakash M., Froelicher V., Do D., Partington S., and Atwood J.E. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346 (2002) 793-801
12. Gulati M., Black H.R., Shaw L.J., et al. The prognostic value of a nomogram for exercise capacity in women. N Engl J Med 353 (2005) 468-475
13. Cole C.R., Blackstone E.H., Pashkow F.J., Snader C.E., and Lauer M.S. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 341 (1999) 1351-1357
14. Arena R., Guazzi M., Myers J., and Peberdy M.A. Prognostic value of heart rate recovery in patients with heart failure. Am Heart J 151 851 (2006) e7-e13
15. Kistorp C., Raymond I., Pedersen F., Gustafsson F., Faber J., and Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. Jama 293 (2005) 1609-1616
16. Gardner R.S., Ozalp F., Murday A.J., Robb S.D., and McDonagh T.A. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 24 (2003) 1735-1743
17. Alonso-Fernandez A., Garcia-Rio F., Arias M.A., et al. Obstructive sleep apnoea-hypoapnoea syndrome reversibly depresses cardiac response to exercise. Eur Heart J 27 (2006) 207-215
18. Lin C.C., Lin C.K., Wu K.M., and Chou C.S. Effect of treatment by nasal CPAP on cardiopulmonary exercise test in obstructive sleep apnea syndrome. Lung 182 (2004) 199-212
19. Tasci S., Manka R., Scholtyssek S., et al. NT-pro-BNP in obstructive sleep apnea syndrome is decreased by nasal continuous positive airway pressure. Clin Res Cardiol 95 (2006) 23-30
20. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
21. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 22 (1999) 667-689
22. Fletcher G.F., Balady G.J., Amsterdam E.A., et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 104 (2001) 1694-1740
23. American College of Sports Medicine. Guidelines for exercise testing and prescription. 6th ed. (2000), Lippincott-Williams & Wilkins, Baltimore
24. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 167 (2003) 211-277
25. Arena R., Myers J., Aslam S.S., Varughese E.B., and Peberdy M.A. Technical considerations related to the minute ventilation/carbon dioxide output slope in patients with heart failure. Chest 124 (2003) 720-727
26. Tanaka H., Monahan K.D., and Seals D.R. Age-predicted maximal heart rate revisited. J Am Coll Cardiol 37 (2001) 153-156
27. Shetler K., Marcus R., Froelicher V.F., et al. Heart rate recovery: validation and methodologic issues. J Am Coll Cardiol 38 (2001) 1980-1987
28. Karl J., Borgya A., Gallusser A., et al. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. Scand J Clin Lab Invest Suppl 230 (1999) 177-181
29. Marin J.M., Carrizo S.J., Vicente E., and Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365 (2005) 1046-1053
30. Conen D., Zeller A., Pfisterer M., and Martina B. Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension. Am J Cardiol 97 (2006) 249-252
31. Mansfield D.R., Gollogly N.C., Kaye D.M., Richardson M., Bergin P., and Naughton M.T. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 169 (2004) 361-366
32. Bradley T.D., Logan A.G., Kimoff R.J., et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 353 (2005) 2025-2033
33. Schlosser B.M., Walther J.W., Rasche K., et al. [Improvement of cardiopulmonary exercise capacity in patients with obstructive sleep apnea syndrome under CPAP therapy]. Med Klin (Munich) 101 (2006) 107-113
34. Myers J., Buchanan N., Walsh D., et al. Comparison of the ramp versus standard exercise protocols. J Am Coll Cardiol 17 (1991) 1334-1342
35. Page E., Cohen-Solal A., Jondeau G., et al. Comparison of treadmill and bicycle exercise in patients with chronic heart failure. Chest 106 (1994) 1002-1006
36. Kaleth A.S., Chittenden T.W., Hawkins B.J., et al. Unique cardiopulmonary exercise test responses in overweight middle-aged adults with obstructive sleep apnea. Sleep Med 8 (2007) 160-168
37. Bonanni E., Pasquali L., Manca M.L., et al. Lactate production and catecholamine profile during aerobic exercise in normotensive OSAS patients. Sleep Med 5 (2004) 137-145
38. Myers J., Gullestad L., Vagelos R., et al. Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med 129 (1998) 286-293
39. 2 slope in patients with heart failure: a prognostic comparison. Am Heart J 147 (2004) 354-360
40. Guazzi M., Myers J., and Arena R. Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure. J Am Coll Cardiol 46 (2005) 1883-1890
41. Gorelik D.D., Hadley D., Myers J., and Froelicher V. Is there a better way to predict death using heart rate recovery?. Clin Cardiol 29 (2006) 399-404
42. Grote L., Hedner J., and Peter J.H. The heart rate response to exercise is blunted in patients with sleep-related breathing disorder. Cardiology 102 (2004) 93-99
43. Brinkworth G.D., Noakes M., Buckley J.D., and Clifton P.M. Weight loss improves heart rate recovery in overweight and obese men with features of the metabolic syndrome. Am Heart J 152 693 (2006) e691-e696
44. Coughlin S.R., Mawdsley L., Mugarza J.A., Wilding J.P., and Calverley P.M. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 29 (2007) 720-727
45. Tschope C., Kasner M., Westermann D., Gaub R., Poller W.C., and Schultheiss H.P. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Eur Heart J 26 (2005) 2277-2284
46. Williams M.H., Handler C.E., Akram R., et al. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension. Eur Heart J 27 (2006) 1485-1494
47. Olsen M.H., Wachtell K., Tuxen C., et al. N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study. J Hypertens 22 (2004) 1597-1604
48. Patwardhan A.A., Larson M.G., Levy D., et al. Obstructive sleep apnea and plasma natriuretic peptide levels in a community-based sample. Sleep 29 (2006) 1301-1306
49. Vartany E., Imevbore M., O'Malley M., et al. N-terminal pro-brain natriuretic peptide for detection of cardiovascular stress in patients with obstructive sleep apnea syndrome. J Sleep Res 15 (2006) 424-429
50. Das S.R., Drazner M.H., Dries D.L., et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 112 (2005) 2163-2168
51. Olsen M.H., Hansen T.W., Christiansen M.K., et al. N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension 46 (2005) 660-666